Home › Therapeutic areas › Ophthalmology › Wet AMD
Wet AMD (6 companies)
Companies with an active program in Wet AMD.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics | OphthalmologyRespiratory Rare | 1 | Phase 3 | $677M | 5 |
| HROW | Harrow | Ophthalmology Rare | 2 | Approved | $1.01B | 15 |
| KOD | Kodiak Sciences | Ophthalmology | 2 | Phase 3 | $6.24B | 8 |
| NBP | NovaBridge Biosciences | OncologyOphthalmology | 1 | Phase 2 | $106M | 7 |
| OCGN | Ocugen | Infectious DiseaseOphthalmology Rare | 1 | Phase 3 | $314M | 12 |
| OTLK | Outlook Therapeutics | Ophthalmology | 1 | Approved | $106M | 3 |
No companies match.